3 Recruiting Differentiated Thyroid Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Related Conditions
Top Recruiting Differentiated Thyroid Cancer Studies
🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
📍 The Unviersity of California, San Francisco (UCSF) — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy
📍 Exelixis Clinical Site #2 — Newport Beach, California
View Study & Checklist ➔